Home  |  Contact

Cellosaurus IIB-BR-G (CVCL_B410)

[Text version]
Cell line name IIB-BR-G
Synonyms Instituto de Investigaciones Bioquimicas-BReast cancer-G
Accession CVCL_B410
Resource Identification Initiative To cite this cell line use: IIB-BR-G (RRID:CVCL_B410)
Comments Population: Caucasian.
Doubling time: ~30 hours (PubMed=1661624).
Derived from site: In situ; Breast; UBERON=UBERON_0000310.
Disease Breast carcinoma (NCIt: C4872)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_T742 (IIB-BR-G-MT)
Sex of cell Female
Age at sampling 50Y
Category Cancer cell line
Publications

PubMed=1661624; DOI=10.1007/BF01975204
Bover L., Barrio M.M., Slavutsky I., Bravo A.I., Quintans C., Bagnati A., Lema B., Schiaffi J., Yomha R., Mordoh J.
Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor.
Breast Cancer Res. Treat. 19:47-56(1991)

PubMed=9620446
Bover L., Barrio M.M., Bravo A.I., Slavutsky I., Larripa I., Bolondi A., Ayala M., Mordoh J.
The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.
Cell. Mol. Biol. 44:493-504(1998)

PubMed=21308409; DOI=10.1007/s10549-011-1360-2
Roberti M.P., Barrio M.M., Bravo A.I., Rocca Y.S., Arriaga J.M., Bianchini M., Mordoh J., Levy E.M.
IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.
Breast Cancer Res. Treat. 130:465-475(2011)

Cross-references
Encyclopedic resources Wikidata; Q54897420
Polymorphism and mutation databases Cosmic; 1507366
Entry history
Entry creation06-Jun-2012
Last entry update29-Jun-2023
Version number11